Remission in psoriatic arthritis: Is it possible and how can it be predicted?

• Main Authors: Saber, T.P, Ng, C.T, Renard, G, Lynch, B.M, Pontifex, E, Walsh, C.A.E, Grier, A, Molloy, M, Bresnihan, B, FitzGerald, O, Fearon, U, Veale, D.J
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: 2020
• Subjects: adalimumab; C reactive protein; disease modifying antirheumatic drug; etanercept; infliximab; methotrexate; steroid; immunoglobulin G; monoclonal antibody; TNFR Fc fusion protein; TNFR-Fc fusion protein; tumor necrosis factor alpha; tumor necrosis factor receptor; adolescent; adult; aged; arthropathy; article; controlled study; demography; female; Health Assessment Questionnaire; human; joint swelling; joint tenderness; major clinical study; male; morning stiffness; outcome assessment; pain assessment; prediction; prospective study; psoriatic arthritis; remission; rheumatoid arthritis; steroid therapy; treatment response; visual analog scale; cohort analysis; disease course; drug antagonism; health survey; metabolism; middle aged; predictive value; retrospective study; statistical model; Adolescent; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; C-Reactive Protein; Cohort Studies; Disease Progression; Female; Health Surveys; Humans; Immunoglobulin G; Linear Models; Male; Middle Aged; Outcome Assessment (Health Care); Predictive Value of Tests; Prospective Studies; Receptors, Tumor Necrosis Factor; Remission Induction; Retrospective Studies; Tumor Necrosis Factor-alpha; Young Adult
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/181668
• Institution: National University of Singapore

10.1186/ar3021